About Amarin Corporation PLC
Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The Company operates in the business segment of development and commercialization of Vascepa. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its Distributors, that in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers. The Company markets Vascepa in the United States.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Drug Manufacturers - Other
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: AMRN
- Previous Close: $3.33
- 50 Day Moving Average: $3.126
- 200 Day Moving Average: $3.117
- 52-Week Range: $1.37 - $3.65
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -11.86
- P/E Growth: -0.040
- Market Cap: $888.57M
- Outstanding Shares: 269,181,000
- Beta: 0.88
- Net Margins: -68.45%
- Return on Assets: -53.64%
Companies Related to Amarin Corporation PLC:
- Debt-to-Equity Ratio: -9.65%
- Current Ratio: 2.15%
- Quick Ratio: 1.88%
What is Amarin Corporation PLC's stock symbol?
Amarin Corporation PLC trades on the NASDAQ under the ticker symbol "AMRN."
Where is Amarin Corporation PLC's stock going? Where will Amarin Corporation PLC's stock price be in 2017?
4 brokerages have issued 1 year price objectives for Amarin Corporation PLC's shares. Their predictions range from $4.50 to $10.00. On average, they anticipate Amarin Corporation PLC's share price to reach $6.38 in the next year.
When will Amarin Corporation PLC announce their earnings?
Amarin Corporation PLC is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns Amarin Corporation PLC stock?
Amarin Corporation PLC's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Broadfin Capital LLC (1.05%), FMR LLC (0.76%), Highland Capital Management LP (0.41%), J. Goldman & Co LP (0.40%), Two Sigma Investments LP (0.21%) and Renaissance Technologies LLC (0.14%).
Who sold Amarin Corporation PLC stock? Who is selling Amarin Corporation PLC stock?
Amarin Corporation PLC's stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, Broadfin Capital LLC, Two Sigma Investments LP and Raymond James Financial Services Advisors Inc..
Who bought Amarin Corporation PLC stock? Who is buying Amarin Corporation PLC stock?
Amarin Corporation PLC's stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, J. Goldman & Co LP, Oxford Asset Management, Dynamic Technology Lab Private Ltd, Commonwealth of Pennsylvania Public School Empls Retrmt SYS, Charlemagne Capital Ltd., Private Advisor Group LLC and State Street Corp.
How do I buy Amarin Corporation PLC stock?
Shares of Amarin Corporation PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Amarin Corporation PLC stock cost?
One share of Amarin Corporation PLC stock can currently be purchased for approximately $3.32.